Harmony Biosciences Holdings Inc (HRMY)
34.36
+0.30
(+0.88%)
USD |
NASDAQ |
Dec 26, 14:32
Harmony Biosciences Holdings Cash from Investing (Quarterly): 0.745M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | -574.40M |
| Dyne Therapeutics Inc | -19.40M |
| Arrowhead Pharmaceuticals Inc | -222.92M |
| Incyte Corp | 38.27M |
| EyePoint Pharmaceuticals Inc | 16.20M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 70.50M |
| Cash from Financing (Quarterly) | -1.175M |
| Free Cash Flow | 220.18M |
| Free Cash Flow Per Share (Quarterly) | 1.213 |
| Free Cash Flow to Equity (Quarterly) | 74.07M |
| Free Cash Flow to Firm (Quarterly) | 70.50M |
| Free Cash Flow Yield | 11.05% |